MedTrace Logo

The Effect Of Lifitegrast On Refractive Accuracy And Symptoms In Dry Eye Patients Undergoing Cataract Surgery

NCT03866629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2020-03-19

No results posted yet for this study

Summary

To determine if Xiidra® lifitegrast plays a role in the refractive accuracy when administered to patients preoperatively who are scheduled for cataract surgery and have a tear break up time (TBUT) ≤ 10 seconds and central corneal staining as defined by the Oxford scale

Conditions

  • Dry Eye

Interventions

DRUG

Lifitegrast

Lifitegrast ophthalmic solution 5%

Sponsors & Collaborators

  • MDbackline, LLC

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2019-10-29
Completion
2019-10-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866629 on ClinicalTrials.gov